SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
Authors
Keywords
-
Journal
NUCLEIC ACIDS RESEARCH
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2022-04-30
DOI
10.1093/nar/gkac382
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Decision rules for identifying combination therapies in open‐entry, randomized controlled platform trials
- (2022) Elias Laurin Meyer et al. PHARMACEUTICAL STATISTICS
- Independent Drug Action in Combination Therapy: Implications for Precision Oncology
- (2022) Deborah Plana et al. Cancer Discovery
- Patient-tailored design for selective co-inhibition of leukemic cell subpopulations
- (2021) Aleksandr Ianevski et al. Science Advances
- Long-acting antiretrovirals: a new era for the management and prevention of HIV infection
- (2021) Paul Thoueille et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery
- (2021) David J. Wooten et al. Nature Communications
- High-throughput screening for drug discovery targeting the cancer cell-microenvironment interactions in hematological cancers
- (2021) Anil K Giri et al. Expert Opinion on Drug Discovery
- Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses
- (2021) Judith M. White et al. mBio
- Predicting Cancer Drug Response In Vivo by Learning an Optimal Feature Selection of Tumour Molecular Profiles
- (2021) Linh C. Nguyen et al. Biomedicines
- SynToxProfiler: An interactive analysis of drug combination synergy, toxicity and efficacy
- (2020) Aleksandr Ianevski et al. PLoS Computational Biology
- SynergyFinder 2.0: visual analytics of multi-drug combination synergies
- (2020) Aleksandr Ianevski et al. NUCLEIC ACIDS RESEARCH
- Rational Cancer Treatment Combinations: An Urgent Clinical Need
- (2020) Julia Boshuizen et al. MOLECULAR CELL
- synergy - A Python library for calculating, analyzing, and visualizing drug combination synergy
- (2020) David J Wooten et al. BIOINFORMATICS
- A statistical framework for assessing pharmacological responses and biomarkers using uncertainty estimates
- (2020) Dennis Wang et al. eLife
- Quantifying Drug Combination Synergy along Potency and Efficacy Axes
- (2019) Christian T. Meyer et al. Cell Systems
- Two-Drug Combinations as First-Step Antihypertensive Treatment
- (2019) Giuseppe Mancia et al. CIRCULATION RESEARCH
- Statistical assessment and visualization of synergies for large-scale sparse drug combination datasets
- (2019) Arnaud Amzallag et al. BMC BIOINFORMATICS
- Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs
- (2019) Geraint Davies et al. PLOS MEDICINE
- Genome-wide off-targets of drugs: risks and opportunities
- (2019) Anil K Giri et al. CELL BIOLOGY AND TOXICOLOGY
- Applying synergy metrics to combination screening data: agreements, disagreements and pitfalls
- (2019) Anna H.C. Vlot et al. DRUG DISCOVERY TODAY
- Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis
- (2019) Huseyin Naci et al. BMJ-British Medical Journal
- Recent advances in combinatorial drug screening and synergy scoring
- (2018) Tea Pemovska et al. CURRENT OPINION IN PHARMACOLOGY
- Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies
- (2017) Stephen E. Kurtz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combenefit: an interactive platform for the analysis and visualization of drug combinations
- (2016) Giovanni Y. Di Veroli et al. BIOINFORMATICS
- Searching for Drug Synergy in Complex Dose–Response Landscapes Using an Interaction Potency Model
- (2015) Bhagwan Yadav et al. Computational and Structural Biotechnology Journal
- Uncovering Scaling Laws to Infer Multidrug Response of Resistant Microbes and Cancer Cells
- (2014) Kevin B. Wood et al. Cell Reports
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now